Announcement PDF ASX Announcement 19 November 2025 JOIN MICROBA’S INTERACTIVE INVESTOR HUB For more Company information and to engage with management by asking questions about Microba’s latest announcements and updates, visit ir.microba.com/welcome Microba Life Sciences Ltd | ABN 82 617 096 652 | L10, 324 Queen Street, Brisbane QLD 4000 Australia | 1300 974 621 Results of Annual General Meeting Microba Life Sciences Limited (ASX: MAP) (“Microba” or the “Company”), advises that its Annual General Meeting of Shareholders was held today at 10.00am AEST (Brisbane Time). The resolutions were voted in accordance with the Notice of Annual General Meeting previously advised to the Australian Securities Exchange (ASX), with all resolutions being passed on a poll. Resolution 3 (Re-election of Dr Hyungtae Kim as a Director) was withdrawn due to Dr. Kim’s retirement as a Director of the Company. Resolution 4 (Approval of 10% Placement Facility) was carried by a sufficient majority as a special resolution. Further information required by section 251AA(2) of the Corporations Act 2001 (Cth) is attached. This announcement has been authorised for release by the Chair and Chief Executive Officer. For further information, please contact: Dr Luke Reid Chief Executive Officer luke.reid@microba.com Investor / Media Relations investor@microba.com https://ir.microba.com/welcome About Microba Life Sciences Limited Microba is at the forefront of microbiome health and human care. With world-leading science, insights and collaboration tools, Microba's vision is to deliver clinical-grade microbiome tests that helps people live healthier, happier lives. Better science. Better insights. Better health. Microba - Expect better. www.microba.com Microba Life Sciences Ltd | ABN 82 617 096 652 | L10, 324 Queen Street, Brisbane QLD 4000 Australia | 1300 974 621 Disclosure of Proxy Votes Microba Life Sciences Limited | Annual General Meeting | Wednesday, 19 November 2025 In accordance with section 251AA of the Corporations Act 2001, the following information is provided in relation to resolutions put to members at the meeting. Results Resolution Decided by Show of Hands (S) or Poll (P) Total Number of Proxy Votes exercisable by proxies validly appointed FOR AGAINST ABSTAIN PROXY'S DISCRETION FOR AGAINST ABSTAIN OUTCOME 255,578,512 21,946,553 0 76,055 256,242,710 21,946,553 0 92.07% 7.91% 0.03% 92.11% 7.89% 346,271,024 3,118,165 142,869 87,165 346,946,332 3,118,165 142,869 99.08% 0.89% 0.02% 99.11% 0.89% 347,606,589 1925469 0 87,165 348,281,897 1,925,469 0 99.42% 0.55% 0.02% 99.45% 0.55% 328,643,831 20160714 738,623 76,055 329,308,029 20,160,714 738,623 94.20% 5.78% 0.02% 94.23% 5.77% P P P Proxy Votes Poll Results (if applicable) 1 - Adoption of Remuneration Report 2 - Re-election of Ms Jacqueline Fernley as a Director of the Company 3 - Re-election of Dr Hyungtae Kim as a Director of the Company Resolution 3 withdrawn due to Dr. Kim's retirement as a Director. 4 - Approval of Additional 10% Placement Facility under ASX Listing Rule 7.1A 5 - Renewal of the Microba Employee Incentive Plan and the issue of equity securities under the Microba Employee Incentive Plan P P 277,601,120 349,476,354 349,619,223 348,880,600 Carried Carried Withdrawn Carried Carried